| BGNE Snapshot | |
|---|---|
| BeiGene, Ltd. discovers, develops, manufactures and markets cancer therapeutics drugs in the People's Republic of China and the United States. The company is headquartered in Beijing, the People's Republic of China. | |
| VALUATION DATA | |
| Market Capitalization | $14,458,594,000 | Price to Sales | 2.00 |
| Earnings per Share | $-8.4600 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $129.5200 |
| 52 Week High | $6.34 |
| 52 Week Low | $4.174 |
| 50-Day Moving Average | $5.43 |
| 200-Day Moving Average | $-11.91 |
| All data are from Alpha Vantage as of today. For more infomation on BGNE see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search